- Home»
- News & Events»
- Press Releases»
- Judd Jessup Former CEO Of US Labs Joins XiFin Board of Directors
Judd Jessup Former CEO Of US Labs Joins XiFin Board of Directors
January 25, 2006XiFin®, Inc., recently named the fifth fastest growing technology company in San Diego, announced today the appointment of Judd Jessup to its Board of Directors. XiFin, using its patented technology, provides highly automated accounts receivable and financial management systems and services to independent clinical and hospital laboratories.
Jessup brings over 30 years experience in managing and building successful healthcare companies. While CEO of US Labs he grew revenues to $75 MM before successfully negotiating its sale to Laboratory Corporation of America (LabCorp) in 2005 at a significant premium to market. Prior to that, Judd was President of the HMO Division of FHP International, which provided healthcare to more than 1.8 million members in 11 states. He joined FHP in 1994, when FHP acquired TakeCare Inc., an HMO operating in California, Colorado, Illinois and Ohio, where Judd had been President since 1987. Judd is credited with TakeCare’s growth from a 150,000 member privately held HMO in Northern California to a multi-state, publicly traded organization with 790,000 members and $1.1 billion in annual revenue. Currently, Judd serves on the Board of Directors for Corvel Corporation, a publicly held workers compensation utilization management company and NovaMed Holdings, Inc., a publicly held eye-care services provider. Judd earned his BA degree from Knox College in Illinois and his MBA from the University of Denver.
“I am very happy to join XiFin’s Board,’ stated Mr. Jessup. “They have a truly revolutionary product and, having been an early adopter of the product while at U.S. Labs, I know the product delivers what it promises. I look forward to helping XiFin become an industry standard.”
“Attracting a business leader of Judd’s stature to our board is a huge win for XiFin,” commented Lale White, Executive Chairman and Founder of XiFin. “His industry knowledge as well as his experience as a XiFin customer will be a great asset and an excellent complement to our existing board members. We are very excited and look forward to working with him.”
Dave Flaugh, XiFin Board member and former LabCorp COO notes, “In addition to his leadership, as a former XiFin customer Judd brings an invaluable perspective, and a tacit acknowledgement and understanding of XiFin’s business model.”
About XiFin
XiFin is an innovative software and services company dedicated to optimizing the economics of healthcare. The company’s cloud-based technology and business intelligence platform links healthcare stakeholders in the delivery and reimbursement of care, optimizing both business and patient outcomes and providing informed, streamlined diagnostic and business decision-making. To learn more, visit www.xifin.com, or follow XiFin on Twitter at www.twitter.com/#!/XiFin.
Recent Press Releases
-
Apr 22, 2026
XiFin to Showcase Empower AI and Provide First Look at Appeals Agent at Executive War College
-
Apr 16, 2026
XiFin Introduces Empower AI for Specialty Pharmacy at Asembia AXS26 and Unveils New Specialty Pharmacy Research Findings
-
Apr 8, 2026
XiFin Partners With Premier Radiology Data Intelligence Leaders Science and Medicine Group and AuntMinnie to Launch First-of-Its-Kind Radiology Research Examining Industry Challenges in 2026 and Beyond
-
Mar 9, 2026
XiFin Announces Empower AI RCM Ecosystem to Redefine How Healthcare Revenue Operations Scale
-
Feb 24, 2026
XiFin Reports Double-Digit Segment Growth and 21.1% Increase in Empower RCM Volume; Names New CTO to Accelerate AI Strategy